Chinese Pharmacopoeia 2020 Edition's 1st Addendum: 54 Additions and 607 Revisions

by Grace Wang Oct 13, 2023

Editor’s notes: The Pharmacopoeia of the People’s Republic of China, also known as Chinese Pharmacopoeia, is a collection of drug standards in China. 

On October 12, 2023, China’s National Medical Products Administration (NMPA) and National Health Commission (NHC) jointly announced the release of the first Addendum to the Chinese Pharmacopoeia 2020 Edition.

The authorities disclosed the contents of the Addendum, but did not provide the main texts. It was stated that the Addendum has been compiled and is planned to be implemented on March 12, 2024.

The Chinese Pharmacopoeia 2020 Edition constitutes four volumes:

Table 1: Volumes of Chinese Pharmacopoeia 2020 Edition

Volume

Content

Number

Volume I

Monographs of traditional Chinese medicines (TCMs)

2,711

Volume II

Monographs of chemical drugs

2,712

Volume III

General monographs of biological products

8

General requirements for biological products

8

Monographs of biological products

153

Volume IV

General chapters

General requirements for preparations

38

General testing methods and other general chapters

281

Guidelines

42

Monographs of pharmaceutical excipients

335

The Addendum includes 54 additions and 607 revisions, which are encapsulated in Table 2:

Table 2: Additions and Revisions in the First Addendum to the Chinese Pharmacopoeia 2020 Edition

Volume

Content

Number

Volume I

Newly added monographs of TCMs

9

Revised monographs of TCMs

94

Volume II

Newly added monographs of chemical drugs

28

Revised monographs of chemical drugs

407

Volume III

Revised general monographs of biological products

2

Revised general requirements for biological products

1

Revised monographs of biological products

45

Newly added general chapters and guidelines for biological products

5

Revised general chapters and guidelines for biological products

4

Volume IV

Newly added guidelines

1

Revised general chapters and guidelines

8

Newly added monographs of excipients

11

Revised monographs of excipients

46

If you are interested in learning more about China's drug standards or getting access to the English version of the Chinese Pharmacopoeia, please feel free to reach out to us. We would be happy to provide you with further information and assist you in obtaining the resources you need.

Subscribe to ChemLinked BaiPharm Newsletter.png

Grace Wang
ChemLinked Regulatory Analyst & Editor
+ FOLLOW
Copyright: unless otherwise stated all contents of this website are ©2024 - REACH24H Consulting Group - All Rights Reserved - For permission to use any content on this site, please contact cleditor@chemlinked.com
You May Also Like
Most Popular